Free Trial Information
BioCentury | Feb 26, 2021
Product Development

The dark of COVID-19 brings promise to Germany’s biotech scene

...peaked at nearly $5 billion last year. Evotec AG (Xetra:EVT) has...
Read More
BioCentury | Dec 12, 2020
Management Tracks

Lum & Dipp’s Biospring rounds out team; plus CHOP’s Smith-Whitley joins GBT and updates from Orphazyme, Kronos, Dewpoint, Enanta and more

...Therapeutics hired Kara Carter as SVP of discovery biology. She was EVP of infectious diseases at Evotec AG...
Read More
BioCentury | Oct 27, 2020
Product Development

Oct. 26 Quick Takes: COVID trips up Spectrum’s Rolontis at FDA; plus Jazz-SpringWorks, Novartis’ iptacopan, Kantaro, Eternygen

...announced the first €5M ($5.9 million) closing of its series A2 round from anchor investor Evotec AG...
Read More
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...Burk, is developing lasso peptides for cancer, autoimmunity, pain and inflammation. TargetsPP2A – Protein phosphatase 2A BC Staff Evotec AG Canaan Rappta Cedilla EdiGene chs2020...
Read More
BioCentury | Aug 6, 2020
Product Development

Aug. 5 Quick Takes: Strong quarterly sales of Horizon’s Tepezza, Global Blood’s Oxbryta; plus a setback for DBV and news from Point, Karuna, Evotec-Secarna, Red

...a Phase III trial in schizophrenia planned for this year. Evotec partners with ASO-focused Secarna Evotec AG...
...SAR164877) DBV Technologies S.A. Point Biopharma Inc. Karuna Therapeutics Inc. Redx Pharma plc AstraZeneca plc Zai Lab Ltd. Deciphera Pharmaceuticals Inc. Secarna Pharmaceuticals GmbH Evotec AG Regeneron...
Read More
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...BI, Evotec Quantro Therapeutics GmbH raised an undisclosed seed round from Boehringer Ingelheim GmbH and Evotec AG...
Read More
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...in series C led by new investor Novo Holdings A/S, with participation from existing investors Evotec AG...
Read More
BioCentury | Apr 23, 2020
Product Development

BioCentury expands COVID-19 gateway to connect biotechs, researchers with COVID R&D consortium members

...to provide a unified platform for comparing activity. Kara Carter, EVP of infectious diseases at Evotec AG...
...Xetra:BAYN); Bristol Myers Squibb Co. (NYSE:BMY); Eisai Co. Ltd. (Tokyo:4523); Eli Lilly and Co. (NYSE:LLY); Evotec AG...
Read More
BioCentury | Apr 18, 2020
Politics, Policy & Law

Collaborating to clobber COVID-19

...Gates Foundation Novartis AG FNIH 5AM Ventures AbbVie Inc. Allergan Inc. Amgen Inc. AstraZeneca plc Bayer AG Bristol Myers Squibb Eisai Co. Ltd. Eli Lilly and Co. Evotec AG Gilead...
Read More
BioCentury | Apr 16, 2020
Deals

COVID R&D: Pharmas align behind crowdsourcing solution

...Myers Squibb Co. C. Simone Fishburn, Editor in Chief Roche Bristol Myers Squibb Co. Evotec Eli Lilly and Co. GlaxoSmithKline plc Novartis AG Evotec AG Versant...
Read More
Items per page:
1 - 10 of 489
BioCentury | Feb 26, 2021
Product Development

The dark of COVID-19 brings promise to Germany’s biotech scene

...peaked at nearly $5 billion last year. Evotec AG (Xetra:EVT) has...
Read More
BioCentury | Dec 12, 2020
Management Tracks

Lum & Dipp’s Biospring rounds out team; plus CHOP’s Smith-Whitley joins GBT and updates from Orphazyme, Kronos, Dewpoint, Enanta and more

...Therapeutics hired Kara Carter as SVP of discovery biology. She was EVP of infectious diseases at Evotec AG...
Read More
BioCentury | Oct 27, 2020
Product Development

Oct. 26 Quick Takes: COVID trips up Spectrum’s Rolontis at FDA; plus Jazz-SpringWorks, Novartis’ iptacopan, Kantaro, Eternygen

...announced the first €5M ($5.9 million) closing of its series A2 round from anchor investor Evotec AG...
Read More
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...Burk, is developing lasso peptides for cancer, autoimmunity, pain and inflammation. TargetsPP2A – Protein phosphatase 2A BC Staff Evotec AG Canaan Rappta Cedilla EdiGene chs2020...
Read More
BioCentury | Aug 6, 2020
Product Development

Aug. 5 Quick Takes: Strong quarterly sales of Horizon’s Tepezza, Global Blood’s Oxbryta; plus a setback for DBV and news from Point, Karuna, Evotec-Secarna, Red

...a Phase III trial in schizophrenia planned for this year. Evotec partners with ASO-focused Secarna Evotec AG...
...SAR164877) DBV Technologies S.A. Point Biopharma Inc. Karuna Therapeutics Inc. Redx Pharma plc AstraZeneca plc Zai Lab Ltd. Deciphera Pharmaceuticals Inc. Secarna Pharmaceuticals GmbH Evotec AG Regeneron...
Read More
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...BI, Evotec Quantro Therapeutics GmbH raised an undisclosed seed round from Boehringer Ingelheim GmbH and Evotec AG...
Read More
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...in series C led by new investor Novo Holdings A/S, with participation from existing investors Evotec AG...
Read More
BioCentury | Apr 23, 2020
Product Development

BioCentury expands COVID-19 gateway to connect biotechs, researchers with COVID R&D consortium members

...to provide a unified platform for comparing activity. Kara Carter, EVP of infectious diseases at Evotec AG...
...Xetra:BAYN); Bristol Myers Squibb Co. (NYSE:BMY); Eisai Co. Ltd. (Tokyo:4523); Eli Lilly and Co. (NYSE:LLY); Evotec AG...
Read More
BioCentury | Apr 18, 2020
Politics, Policy & Law

Collaborating to clobber COVID-19

...Gates Foundation Novartis AG FNIH 5AM Ventures AbbVie Inc. Allergan Inc. Amgen Inc. AstraZeneca plc Bayer AG Bristol Myers Squibb Eisai Co. Ltd. Eli Lilly and Co. Evotec AG Gilead...
Read More
BioCentury | Apr 16, 2020
Deals

COVID R&D: Pharmas align behind crowdsourcing solution

...Myers Squibb Co. C. Simone Fishburn, Editor in Chief Roche Bristol Myers Squibb Co. Evotec Eli Lilly and Co. GlaxoSmithKline plc Novartis AG Evotec AG Versant...
Read More
Items per page:
1 - 10 of 489